Viewing Study NCT05705466


Ignite Creation Date: 2025-12-24 @ 4:23 PM
Ignite Modification Date: 2025-12-31 @ 9:11 PM
Study NCT ID: NCT05705466
Status: WITHDRAWN
Last Update Posted: 2024-03-22
First Post: 2023-01-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Navtemadlin Plus Pembrolizumab as Maintenance Therapy in Locally Advanced and Metastatic Non-Small Cell Lung Cancer
Sponsor: Kartos Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module